Franklin Resources Inc Grifols Sa Transaction History

Franklin Resources Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$7.71 - $11.56 $2,459 - $3,687	319 Added 2.2%	14,812 $171,000
Q3 2023 Nov 13, 2023	BUY	$8.91 - $10.91 $2,191 - $2,683	246 Added 1.73%	14,493 $132,000
Q2 2023 Aug 11, 2023	SELL	$7.14 - $9.29 $24,197 - $31,483	-3,389 Reduced 19.22%	14,247 $130,000
Q1 2023 May 12, 2023	SELL	$6.65 - $10.69 $11,537 - $18,547	-1,735 Reduced 8.96%	17,636 $129,000
Q4 2022 Feb 10, 2023	BUY	$5.96 - $8.53 $115,451 - $165,234	19,371 New	19,371 $164,000
Q2 2022 Aug 11, 2022	BUY	$10.6 - $13.28 $108,512 - $135,947	10,237 Added 74.06%	24,059 $286,000
Q1 2022 May 13, 2022	BUY	$10.37 - $12.73 $1,856 - $2,278	179 Added 1.31%	13,822 $161,000
Q4 2021 Feb 11, 2022	BUY	$10.21 - $15.27 $139,295 - $208,328	13,643 New	13,643 $153,000

164

140M

268K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $4.68B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.